When it comes to cardiovascular health, few supplements have sparked as much public interest — or confusion — as nattokinase.
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results